University of Technology Sydney

96065 Process Development for Therapeutics: A Perspective for Finished Dose Forms

6cp; Standard mode: 3hpw (on campus workshop); Distance mode: offered fully online, requiring no on-campus attendance
Requisite(s): 96057 GMP for Manufacturing Operations AND 96134 Validation Principles and Practices AND 96059 International GMPs and Quality Assurance AND 96060 Good (Quality Control) Laboratory Practices AND 96069 Contamination Control AND 96062 Good Aseptic Practices and Sterile Products AND 96063 GxP and Quality Auditing Practices AND 96064 Risk Management for Pharmaceutical Operations
There are course requisites for this subject. See access conditions.


Solid and topical semisolids, such as tablets and creams respectively, are common dose forms produced in the pharmaceutical industry. This subject guides students through the manufacturing process of common dose forms, from required starting materials through to formulation, steps in manufacturing and final product packaging. Students develop an understanding of how full-scale manufacturing technologies function, as well as the strategic skills required for process optimisation and validation. The impact of quality assurance on finished dose forms and the importance of quality management are also studied.

Typical availability

Autumn session, City campus

Detailed subject description.

Access conditions

Note: The requisite information presented in this subject description covers only academic requisites. Full details of all enforced rules, covering both academic and admission requisites, are available at access conditions and My Student Admin.